Comment on: “Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy” by Zhou et al.

Documenti analoghi

• The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
  di: Zhou, Haiyan, et al.
  Pubblicazione: (2020)
• The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al.
  di: Haiyan Zhou, et al.
  Pubblicazione: (2020-10-01)
• Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy
  di: Zhou, Haiyan, et al.
  Pubblicazione: (2020)
• Antisense Oligonucleotides for the Treatment of Spinal Muscular Atrophy
  di: Porensky, Paul N., et al.
  Pubblicazione: (2013)
• Antisense oligonucleotides and spinal muscular atrophy: skipping along
  di: Burghes, Arthur H.M., et al.
  Pubblicazione: (2010)